Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2000 1
2002 2
2003 1
2004 1
2005 1
2006 2
2007 1
2009 1
2011 1
2012 1
2013 3
2014 5
2015 2
2016 4
2017 4
2018 4
2019 1
2020 7
2021 7
Text availability
Article attribute
Article type
Publication date

Search Results

43 results
Results by year
Filters applied: . Clear all
Page 1
Nausea and vomiting in early pregnancy.
Festin M. Festin M. BMJ Clin Evid. 2014 Mar 19;2014:1405. BMJ Clin Evid. 2014. PMID: 24646807 Free PMC article. Review.
INTRODUCTION: More than half of pregnant women suffer from nausea and vomiting, which typically begins by the fourth week and disappears by the 16th week of pregnancy. The cause of nausea and vomiting in pregnancy is unknown, but may be due to the rise in human chor …
INTRODUCTION: More than half of pregnant women suffer from nausea and vomiting, which typically begins by the fourth week and disappears by …
Managing Migraine During Pregnancy and Lactation.
Wells RE, Turner DP, Lee M, Bishop L, Strauss L. Wells RE, et al. Curr Neurol Neurosci Rep. 2016 Apr;16(4):40. doi: 10.1007/s11910-016-0634-9. Curr Neurol Neurosci Rep. 2016. PMID: 27002079 Review.
Non-pharmacological migraine treatments can be instituted in advance of pregnancy as many are considered the safest options during pregnancy, but understanding the safety of medications and dietary supplements ensures appropriate care for the refractory migra …
Non-pharmacological migraine treatments can be instituted in advance of pregnancy as many are considered the safest options during …
Ondansetron Use in Pregnancy.
Siminerio LL, Bodnar LM, Venkataramanan R, Caritis SN. Siminerio LL, et al. Obstet Gynecol. 2016 May;127(5):873-877. doi: 10.1097/AOG.0000000000001375. Obstet Gynecol. 2016. PMID: 27054931 Free PMC article.
An efficacious treatment used widely across the United States for both nausea and vomiting of pregnancy and hyperemesis gravidarum is ondansetron. Recent studies have provided conflicting findings on the safety of ondansetron during pregnancy. T …
An efficacious treatment used widely across the United States for both nausea and vomiting of pregnancy and hyperemesis gravidarum is …
Association of Maternal First-Trimester Ondansetron Use With Cardiac Malformations and Oral Clefts in Offspring.
Huybrechts KF, Hernández-Díaz S, Straub L, Gray KJ, Zhu Y, Patorno E, Desai RJ, Mogun H, Bateman BT. Huybrechts KF, et al. JAMA. 2018 Dec 18;320(23):2429-2437. doi: 10.1001/jama.2018.18307. JAMA. 2018. PMID: 30561479 Free PMC article.
IMPORTANCE: Evidence for the fetal safety of ondansetron, a 5-HT3 receptor antagonist that is commonly prescribed for nausea and vomiting during pregnancy, is limited and conflicting. OBJECTIVE: To evaluate the association between ondansetron exposure …
IMPORTANCE: Evidence for the fetal safety of ondansetron, a 5-HT3 receptor antagonist that is commonly prescribed for nausea a …
Ondansetron use in early pregnancy and the risk of miscarriage.
Suarez EA, Boggess K, Engel SM, Stürmer T, Lund JL, Jonsson Funk M. Suarez EA, et al. Pharmacoepidemiol Drug Saf. 2021 Feb;30(2):103-113. doi: 10.1002/pds.5143. Epub 2020 Oct 12. Pharmacoepidemiol Drug Saf. 2021. PMID: 33000871
BACKGROUND: Ondansetron is commonly used to treat nausea and vomiting in pregnancy despite inconclusive evidence of its safety. ...CONCLUSIONS: We did not observe an increase in the risk of miscarriage for pregnancies exposed to ondansetron vs c …
BACKGROUND: Ondansetron is commonly used to treat nausea and vomiting in pregnancy despite inconclusive evidence of its saf
Ondansetron and pregnancy: Understanding the data.
Kennedy D. Kennedy D. Obstet Med. 2016 Mar;9(1):28-33. doi: 10.1177/1753495X15621154. Epub 2015 Dec 23. Obstet Med. 2016. PMID: 27512487 Free PMC article. Review.
Following the thalidomide tragedy of 55 years ago there is a particular awareness and sensitivity about these potential risks, especially in relation to any medication used to treat NVP. Despite several studies showing no clear benefits of ondansetron over other NVP treatm …
Following the thalidomide tragedy of 55 years ago there is a particular awareness and sensitivity about these potential risks, especially in …
Nausea and vomiting in early pregnancy.
Festin M. Festin M. BMJ Clin Evid. 2009 Jun 3;2009:1405. BMJ Clin Evid. 2009. PMID: 21726485 Free PMC article. Review.
INTRODUCTION: More than half of pregnant women suffer from nausea and vomiting, which typically begins by the 4th week and disappears by the 16th week of pregnancy. The cause of nausea and vomiting in pregnancy is unknown, but may be due to the rise in human chorion …
INTRODUCTION: More than half of pregnant women suffer from nausea and vomiting, which typically begins by the 4th week and disappears by the …
Interventions for treating hyperemesis gravidarum: a Cochrane systematic review and meta-analysis.
Boelig RC, Barton SJ, Saccone G, Kelly AJ, Edwards SJ, Berghella V. Boelig RC, et al. J Matern Fetal Neonatal Med. 2018 Sep;31(18):2492-2505. doi: 10.1080/14767058.2017.1342805. Epub 2017 Jul 11. J Matern Fetal Neonatal Med. 2018. PMID: 28614956 Review.
INTRODUCTION: While nausea and vomiting in early pregnancy are very common, affecting approximately 80% of the pregnancies, hyperemesis gravidarum is a severe form affecting 0.3-1.0% of the pregnancies. ...It is one of the most common indications for hospital …
INTRODUCTION: While nausea and vomiting in early pregnancy are very common, affecting approximately 80% of the pregnancies, hy …
Gaining Insight Into Ondansetron Safety in Early Pregnancy.
Lavecchia M, Chari R, Ross S. Lavecchia M, et al. J Obstet Gynaecol Can. 2019 Apr;41(4):419-420. doi: 10.1016/j.jogc.2019.01.001. Epub 2019 Jan 24. J Obstet Gynaecol Can. 2019. PMID: 30685231 No abstract available.
43 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page